Skip to main content
. 2022 Feb 4;11(5):1310–1323. doi: 10.1002/cam4.4551

Table 1.

Global burden of primary liver cancer by gender, etiology, and region from 1990 to 2019

Characteristic 1990 2019 1990–2019
Incident cases, no. ×103 (95% UI) ASR per 100000, no. (95% UI) Incident cases, no. × 103 (95% UI) ASR per 100000, no. (95% UI) EAPCs, no. (95% CI)
Global 373 (336 to 416) 8.98 (8.10 to 9.97) 534 (487 to 589) 6.51 (5.95 to 7.16) −1.93 (−2.30 to −1.55)
Sociodemographic index
High SDI 53 (52 to 55) 5.27 (5.11 to 5.39) 140 (126 to 154) 7.61 (6.88 to 8.36) 0.91 (0.47 to 1.35)
High‐middle SDI 109 (95 to 123) 9.92 (8.73 to 11.20) 107 (94 to 121) 5.34 (4.70 to 6.04) −3.3 (−3.89 to −2.77)
Middle SDI 166 (144 to 194) 14.73 (12.80 to 17.04) 186 (162 to 211) 7.32 (6.41 to 8.28) −2.86 (−3.41 to −2.31)
Low‐middle SDI 35 (31 to 39) 5.36 (4.85 to 5.93) 55 (50 to 62) 3.99 (3.60 to 4.44) −1.62 (−1.94 to −1.30)
Low SDI 10 (9 to 12) 4.08 (3.58 to 4.63) 19 (17 to 22) 3.51 (3.11 to 3.91) −0.28 (−0.36 to −0.21)
Gender
Male 260 (227 to 298) 13.07 (11.42 to 14.87) 376 (335 to 422) 9.71 (8.69 to 10.84) −1.92 (−2.33 to −1.51)
Female 113 (99 to 129) 5.22 (4.62 to 5.96) 158 (140 to 176) 3.63 (3.23 to 4.05) −1.87 (−2.16 to 1.59)
Etiology
HBV 198 (166 to 232) 4.60 (3.86 to 5.39) 219 (186 to 255) 2.62 (2.24 to 3.05) −3.10 (−3.66 to −2.53
HCV 84 (73 to 96) 2.19 (1.90 to 2.49) 152 (132 to 175) 1.90 (1.64 to 2.17) −1.04 (−1.27 to −0.81)
Alcohol 48 (38 to 59) 1.20 (0.96 to 1.47) 98 (79 to 120) 1.19 (0.96 to 1.45) −0.40 (−0.57 to −0.22)
NASH 18 (15 to 21) 0.44 (0.36 to 0.53) 36 (29 to 45) 0.45 (0.37 to 0.55) −0.51 (−0.79 to −0.24)
Others 25 (21 to 30) 0.56 (0.47 to 0.67) 28 (24 to 34) 0.35 (0.29 to 0.42) −2.42 (−2.86 to −1.99)
Region
North Africa and Middle East 11 (9 to 12) 6.08 (5.28 to 6.81) 28 (22 to 34) 6.29 (5.13 to 7.71) 0.49 (0.32 to 0.67)
High‐income Asia Pacific 28 (27 to 29) 13.77 (13.3 to 14.19) 68 (58 to 78) 15.56 (13.46 to 17.74) −0.17 (−08 to 0.39)
Tropical Latin America 2 (2 to 2) 1.97 (1.88 to 2.04) 6 (5 to 6) 2.36 (2.22 to 2.48) 1.05 (0.89 to 1.21)
Eastern Sub‐Saharan Africa

2 (2 to 3)

2.93 (2.44 to 3.7) 5 (4 to 7) 3.13 (2.6 to 3.81) −0.03 (−0.15 to 0.1)
Australasia 0.5 (0.5 to 0.5) 2.05 (1.97 to 2.13) 2 (2 to 3) 4.59 (3.72 to 5.68) 3.14 (2.87 to 3.41)
Western Sub‐Saharan Africa 5 (4 to 6) 5.45 (4.60 to 6.32) 10 (8 to 11) 4.93 (4.19 to 5.72) −0.47 (−0.54 to −0.39)
Andean Latin America 1 (0.9 to 1) 4.90 (4.31 to 5.52) 2 (1 to 2) 3.11 (2.55 to 3.78) −2.01 (−2.45 to −1.57)
Central Europe 8 (7 to 8) 5.25 (5.06 to 5.39) 7 (6 to 8) 3.29 (2.85 to 3.81) −1.32 (−1.69 to −0.96)
Southern Latin America 0.7 (0.6 to 0.8) 1.56 (1.41 to 1.71) 2 (2 to 2) 2.33 (1.83 to 2.92) 2.05 (1.81 to 2.30)
South Asia 16 (13 to 18) 2.66 (2.2 to 3.08) 38 (33 to 43) 2.66 (2.30 to 3.05) −0.02 (−0.10 to 0.06)
East Asia 241 (204 to 85) 25.26 (21.46 to 29.74) 217 (181 to 257) 10.43 (8.76 to 12.30) −4.60 (−5.39 to −3.80)
Southeast Asia 17 (15 to 19) 6.43 (5.69 to 7.06) 43 (35 to 52) 7.07 (5.87 to 8.61) 0.31 (0.25 to 0.37)
Central Latin America 3 (3 to 3) 3.49 (3.24 to 3.68) 8 (7 to 9) 3.43 (2.96 to 3.97) 0.11 (−0.22 to 0.43)
High‐income North America 8 (7 to 8) 2.20 (2.14 to 2.25) 31 (26 to 37) 5.18 (4.28 to 6.18) 2.99 (2.79 to 3.20)
Caribbean 2 (1 to 2) 5.94 (5.52 to 6.30) 2 (1 to 2) 3.16 (2.63 to 3.77) −2.09 (−2.89 to −1.28)
Southern Sub‐Saharan Africa 2 (1 to 3) 6.47 (4.52 to 10.72) 4 (4 to 5) 6.77 (6.07 to 7.61) −0.43 (−1.00 to 0.14)
Oceania 0.1 (0.01 to 0.1) 3.65 (3.08 to 4.25) 0.2 (0.1 to 0.3) 3.28 (2.77 to 3.89) −0.22 (−0.28 to −0.16)
Eastern Europe 4 (4 to 4) 1.52 (1.45 to 1.59) 9 (8 to 11) 2.84 (2.46 to 3.24) 2.52 (2.27 to 2.78)
Central Sub‐Saharan Africa 0.7 (0.6 to 0.8) 2.63 (2.20 to 3.08) 1 (1 to 2) 2.30 (1.84 to 2.86) −0.61 (−0.68 to −0.539)
Central Asia 1 (1 to 2) 3.13 (2.79 to 3.47) 6 (5 to 7) 8.27 (7.22 to 9.41) 2.78 (2.24 to 3.32)
Western Europe 20 (19 to 21) 3.55 (3.43 to 3.64) 46 (40 to 53) 5.31 (4.59 to 6.12) 1.37 (1.19 to 1.55)

Abbreviations: ASR, age‐standardized incidence rate; EPAC, the estimated annual percentage change.